Illumina Inc

Business

FDA says it is ‘working around the clock’ to support Covid vaccine approvals for kids under age 12

Today News || 12-year-old Justing Concepcion receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19) from registered…

Read More »
Business

Dr. Scott Gottlieb says daily new Covid cases in the U.S. won’t ever go to zero

Today News || The U.S. is “never going to have zero” new daily Covid cases, Dr. Scott Gottlieb told CNBC on…

Read More »
Business

Stocks making the biggest moves midday: Illumina, BP, Snap & more

Today News || Check out the companies making headlines in midday trading.  Snap — The social media company’s stock price…

Read More »
Business

Dr. Scott Gottlieb says Americans will be getting together well before Biden’s July 4 target

Today News || Dr. Scott Gottlieb told CNBC on Friday he thinks many Americans will start holding group gatherings well before President…

Read More »
Business

Oxford researcher confident Covid vaccines can be adapted to protect against future virus strains

Today News || Sir John Bell, a professor at Oxford University in the U.K., told CNBC on Wednesday he was…

Read More »
Business

Stocks making the biggest moves midday: Peloton, Apple, IAC, CarMax and more

Today News || A monitor displays Peloton Interactive Inc. signage during the company’s initial public offering (IPO) across from the…

Read More »
Business

The CDC is expected to shorten Covid quarantine time, something most everyone seems to agree on

Today News || The U.S. Centers for Disease Control and Prevention is considering shortening its recommended two-week quarantine period for…

Read More »

Dr. Scott Gottlieb: U.S. at Covid ‘tipping point’ but can still prevent new ‘exponential spread’

Today News || Dr. Scott Gottlieb on Monday warned that the United States is “at a tipping point” in its…

Read More »

Dr. Scott Gottlieb warns of ‘staggering’ Covid death totals in U.S. as infection rates increase

Today News || The United States could see “staggering” numbers of coronavirus deaths in the coming months as infection rates…

Read More »

Gilead CEO: ‘We have ample supply’ of remdesivir for hospitalized coronavirus patients

Today News || Gilead Sciences will have sufficient global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel…

Read More »
Back to top button
Close